Business Wire

Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly

22.5.2026 13:45:00 CEST | Business Wire | Press release

Share

Global teams recognised in the Future Health Challenge for solutions designed to detect health risks earlier and support faster health system decisions Future Health – A Global Initiative by Abu Dhabi and MIT Solve announce the winners of the inaugural Future Health ChallengeWinning solution equips frontline health workers in low-resource settings with mobile clinical decision-support tools, enabling earlier detection and more effective care deliveryTeams competed for a USD 200,000 grand prize and two USD 50,000 runner-up awards on the sidelines of the 79th World Health Assembly in GenevaWinners recognised for solutions advancing anticipatory, data-driven health systems

Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, signalling a shift in health systems from late-stage treatment to earlier intervention.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522587414/en/

Selected from 393 submissions across 68 countries, the winning teams were recognised through the inaugural ‘Future Health Challenge 2026: Building Anticipatory Health Systems through Population Sensing’, delivered by Future Health – A Global Initiative by Abu Dhabi in collaboration with MIT Solve.

Health systems globally are facing rising costs and persistent delays in diagnosis, with many conditions still identified only after symptoms become severe. At the same time, access to prevention remains unequal, with underserved communities often facing the greatest barriers to early screening and timely care, as well as reliable health information. The Future Health Challenge focused on solutions designed to detect health risks sooner, monitor population-level data, and support faster decision-making by health authorities.

Five finalist teams presented their solutions to an international audience spanning global health, philanthropy, investment, technology and life sciences, with the judging team awarding prizes to the following teams:

  • ThinkMD, Australia
    USD 200,000, Winner
    ThinkMD equips frontline health workers with mobile clinical decision-support tools that improve triage, treatment, and referral, while turning routine care encounters into real-time population health signals. The platform is already used by more than 9,000 frontline workers across 885 facilities, with the platform’s ability to act as an early warning system demonstrated through previously detected symptom patterns preceding a cholera outbreak in Zambia.

  • Vector Control Innovations, United States
    USD 50,000, Distinguished Finalist
    VectorCam uses AI-enabled mosquito surveillance to detect changing vector risks earlier, helping health systems target interventions before outbreaks escalate. Field evaluations of VectorCam’s impact have shown clear improvements in both efficiency and data quality, with evaluations showing data completeness increasing from around 60% to over 90%.

  • Huna, Brazil
    USD 50,000, Distinguished Finalist
    Huna applies AI to routine blood test data to identify people at elevated cancer risk earlier and guide them into appropriate screening and care pathways. In Brazil, its pilots have screened more than 500,000 patients, and across all deployments to date, hundreds of cancer cases have been detected, many of which would likely have been found later when treatment is more complex and expensive.

Delivered in collaboration with MIT Solve, the Future Health Challenge is part of Future Health’s year-round programme of activities designed to identify and champion high-potential talent globally, connecting innovators with funding, partnerships and pathways to scale solutions that advance longer, healthier lives.

Dr. Jackie Rabec, Co-Founder of ThinkMD, said: “We are thrilled to be the recipients of this award, and we are excited to be able to use it to scale our impact. Our next stage of growth will be expanding in priority markets across Nigeria, Rwanda, Uganda and Somalia, validating our next generation multimodal conversational interface and furthering our self-care product to deliver health intelligence into the hands of citizens.”

Dr. Asma Al Mannaei, Executive Director of the Health and Life Sciences Sector at the Department of Health – Abu Dhabi said “Too often, health systems only detect risk once it has become illness, when treatment is more complex and outcomes are worse. Solutions from the Future Health Challenge are designed to identify risk earlier and support more timely decisions at a population level. The priority now is testing and scaling what works in real-world settings.”

Hala Hanna, Executive Director of MIT Solve, said: “The solutions emerging from this Challenge reflect both the urgency and the opportunity facing health systems globally. By bringing innovators together with policymakers, funders and implementers through platforms such as Future Health, we can help accelerate solutions that are locally grounded and capable of delivering impact at scale.”

MIT Solve has more than a decade of experience in delivering global innovation challenges across health, climate, learning and economic prosperity. To date, MIT Solve has mobilised over USD 80 million in funding for innovators worldwide, with supported solutions reaching more than 370 million lives.

The Challenge forms part of Future Health’s purpose to identify and support innovations that improve health outcomes. Beyond prize funding, participating teams will be connected to partners, investors and health authorities to support the next phase of development and adoption.

Representatives from finalist, semi-finalist and selected Honourable Mention teams will also be invited to showcase their innovations at the Abu Dhabi Future Health Summit, taking place from 20 to 22 October 2026.

Future Health continues to advance a year-round programme across longevity and precision medicine, intelligent health and AI, health system resilience and sustainability, and investment in life sciences, to empower better health worldwide. The platform will continue to introduce new opportunities for global collaboration and discovery of impactful solutions throughout the year.

For more information about the Future Health Challenge and upcoming programme milestones, visit www.futurehealthinitiative.ae

View source version on businesswire.com: https://www.businesswire.com/news/home/20260522587414/en/

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Novotech Strengthens Presence in Japan with Opening of Tokyo Office24.8.2026 01:01:00 CEST | Press release

Novotech, a leading global biotech CRO and full-service clinical research organization, has strengthened its established presence in Japan with the opening of a new office in Tokyo. The investment builds on Novotech’s existing operations and clinical trial activity in Japan and further enhances its ability to support Japanese biopharma companies as they advance programs regionally and across key international markets. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260823592174/en/ Takeshi Mori, Novotech Country Head, Japan The Tokyo office will serve as a strategic hub for Novotech’s growing operations in Japan, providing enhanced local expertise and strengthening collaboration with clients, partners, research institutions, and innovation ecosystems across the region. Novotech is currently supporting ongoing studies in Japan and provides sponsors with integrated support across early-phase clinical development in Australia, F

FDA Authorizes ZYN ULTRA Nicotine Pouches Following Scientific Review21.8.2026 21:11:00 CEST | Press release

Authorizations add selection of ZYN ULTRA products to PMI U.S.’s growing portfolio of better alternatives for legal-age adults who smoke or use traditional oral tobacco products Philip Morris International Inc. (NYSE: PM) today announces that the U.S. Food and Drug Administration (FDA) issued Marketing Granted Orders to PMI’s U.S. affiliate, Swedish Match USA, Inc., authorizing the marketing of 11 ZYN ULTRA moist oral nicotine pouch products, including all 9mg variants and one 11mg variant. Additional 11mg variants remain under scientific review. Today’s action further enhances PMI’s leadership role in the smoke-free category. “We are delighted with the FDA’s decision to authorize a range of ZYN ULTRA products, which will build on ZYN’s position as America’s leading smoke-free product brand,” said Stacey Kennedy, PMI U.S. CEO. “We look forward to expanding our portfolio of better choices for the 45 million Americans who consume nicotine products.” ZYN ULTRA positions the brand to furth

58% of Consumers Say They Don't Care Whether a Product is a National Brand or Private Label. They Just Buy What They Need21.8.2026 12:00:00 CEST | Press release

New NIQ & World Data Lab report reveals how consumer polarization is redefining value, accelerating private label adoption, and reshaping competition on the shelf As fast-moving consumer goods (FMCG) prices rose 26% globally between 2021 and 2025, consumers have become more deliberate about where they save and where they spend. NielsenIQ (NYSE: NIQ) has released new findings showing that private label is no longer viewed simply as a lower-cost substitute, but as a credible competitor across value, mainstream, and premium segments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260819950224/en/ Private label is no longer just a value play. The findings, published in NIQ’s latest report, A Tale of Two Consumers: The Polarized Mindsets Reshaping Global Consumption, created in collaboration with World Data Lab, show how consumer polarization is redefining value and reshaping competition on the shelf. The report also draws on ins

Tanium Reappoints Co-Founder Orion Hindawi as CEO to Drive Next Chapter of Growth20.8.2026 21:10:00 CEST | Press release

Company to focus on deepening its Autonomous IT capabilities, further expanding AI offerings across its portfolio, and strengthening customer and partner engagement Tanium, a leader in Autonomous IT, today announced that Co-Founder and Executive Chairman Orion Hindawi has been appointed Chief Executive Officer, effective immediately. Dan Streetman is stepping down as CEO and as a member of the Board after leading Tanium for the last three years, during which time Tanium scaled its go-to-market operations and secured strong industry analyst recognition for innovation within the Tanium platform. Streetman will continue to advise Tanium as part of the transition and co-founder David Hindawi will return to the role of Chairman of the Board. With this foundation in place, this transition positions Tanium to deepen its Autonomous IT capabilities and further expand AI offerings across its portfolio and strengthen customer and partner engagement. The Hindawis co-founded Tanium in 2007 to build

PCI Energy Solutions to Join Mitsubishi Electric, Reinforcing Long-Term Commitment to Customers, Employees, and the Energy Industry20.8.2026 19:46:00 CEST | Press release

Mitsubishi Electric to retain PCI’s core management team and support continuity of operations, customer service, and product innovation PCI Energy Solutions ("PCI"), a leading U.S.-based provider of enterprise software for energy management and optimization, announced today that it has entered into a definitive agreement to be acquired by Mitsubishi Electric Corporation. The agreement was executed on August 20, 2026 (Japan Standard Time). The Transaction represents a strong endorsement of PCI's business, technology, employees, customer relationships and position in the energy industry. Mitsubishi Electric intends to retain PCI's core management team following completion of the Transaction, enabling PCI to preserve leadership continuity, industry expertise and its customer-focused operating model while benefiting from Mitsubishi Electric's global scale, complementary capabilities and long-term investment capacity. The agreement has been signed, but the Transaction has not yet closed. PC

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye